MY144022A - Simple method of transplanting injectable chondrocyte for autologous chondrocyte transplantation - Google Patents
Simple method of transplanting injectable chondrocyte for autologous chondrocyte transplantationInfo
- Publication number
- MY144022A MY144022A MYPI20080125A MY144022A MY 144022 A MY144022 A MY 144022A MY PI20080125 A MYPI20080125 A MY PI20080125A MY 144022 A MY144022 A MY 144022A
- Authority
- MY
- Malaysia
- Prior art keywords
- vial
- syringe
- chondrocyte
- injecting
- transplanting
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
Abstract
THE PRESENT INVENTION RELATES TO A METHOD OF TRANSPLANTING AN INJECTABLE CHONDROCYTE FOR AUTOLOGOUS CHONDROCYTE TRANSPLANTATION. FOR THIS PURPOSE, THE PRESENT INVENTION PROVIDES A METHOD OF TRANSPLANTING AN INJECTABLE CHONDROCYTE FOR AUTOLOGOUS CHONDROCYTE TRANSPLANTATION, COMPRISING MIXING MATRICES INCLUDING FIBRIN, HYALURONIC ACID AND COLLAGEN, CONSTITUTING MAIN INGREDIENTS OF ANIMAL CARTILAGE, VIA USE OF A FRONT END MIXING TIP OF A SYRINGE, WHILE INJECTING THE RESULTING MIXTURE INTO A DAMAGED CARTILAGE REGION. FURTHER, THE PRESENT INVENTION PROVIDES A METHOD OF TRANSPLANTING AN INJECTABLE CHONDROCYTE FOR AUTOLOGOUS CHONDROCYTE TRANSPLANTATION, COMPRISING PLACING 1 ML OF A CHONDROCYTE CULTURE CONTAINED IN VIAL NO. 1 (RED) INTO A 1 ML STERILE SYRINGE AND INJECTING THE CELL CULTURE INTO VIAL NO. 2 (BLUE) CONTAINING WHITE OR LIGHT-YELLOW LYOPHILIZED POWDER (FIBRINOGEN) BY INSERTING THE SYRINGE INTO VIAL NO. 2 IN THE VERTICAL DIRECTION, SUCH THAT THE CONCENTRATION OF FIBRINOGEN IS IN THE RANGE OF 10 MG/ML TO 200 MG/ML; INJECTING 1 ML OF CELL CULTURE CONTAINED IN VIAL NO. 1 (RED) INTO VIAL NO. 3 (RED, SMALL) CONTAINING WHITE LYOPHILIZED POWDER (THROMBIN) BY INSERTING THE SYRINGE INTO VIAL NO. 3 IN THE VERTICAL DIRECTION, THEREBY GRADUALLY INJECTING RED LIQUID; COLLECTING 0.1 CC OF 1 ML CONTENT OF VIAL NO. 3 (RED, SMALL) USING A 1 ML SYRINGE, FOLLOWED BY INJECTION INTO A BOTTOM OF VIAL NO.4 (YELLOW) SUCH THAT THE CONCENTRATION OF THROMBIN IS IN THE RANGE OF 1 IU/ML TO 200 IU/ML; ADDING THE ENTIRE CONTENTS OF TWO VIALS CONTAINING CHONDROCYTE SUSPENSION TO VIAL NO.4 (YELLOW) USING A 1ML STERILE SYRINGE, FOLLOWED BY MIXING THE CONTENTS TWO OR THREE TIMES USING THE SYRINGE; CONFIRMING COMPLETE DISSOLUTION OF THE CONTENTS OF VIAL NO.2 (BLUE) AND THEN INJECTING THE ENTIRETY OF THE DISSOLVED MATERIAL INTO A 1 ML SYRINGE; INJECTING THE WELL-MIXED CELL THERAPEUTIC AGENT OF VIAL 4 (YELLOW) INTO A 1 ML SYRINGE; AND MOUNTING TWO 1 ML SYRINGES FILLED WITH THE CONTENTS OF VIAL NO.2 (BLUE) AND VIAL NO.4 (YELLOW) ON A STANDING HOLDER FOLLOWED BY MOUNTING A SCREW TIP ON THE SYRINGES, AND MIXING THE CONTENTS OF THE SYRINGES USING FRONT END MIXING TIP THEREOF WHILE INJECTING THE RESULTING MIXTURE TO BE TRANSPLANTED INTO A DAMAGED CARTILAGE REGION OF AN ANIMAL. THE PRESENT INVENTION HAVING THE ABOVE-MENTIONED CONSTRUCTION PROVIDES ADVANTAGEOUS EFFECTS SUCH AS SOLUTION OF INCONVENIENCE EXHIBITED BY CONVENTIONAL OSTEOPERIOSTEAL GRAFTING, BY MIXING AND TRANSPLANTING MATRICES INCLUDING FIBRIN, HYALURONIC ACID AND COLLAGEN WHICH ARE MAIN INGREDIENTS OF CARTILAGE; TREATMENT OF A WIDE VARIETY OF CARTILAGE DEFECTS AND SEVERE OSTEOARTHRITIS; ALLEVIATION OF BURDEN OF PATIENTS TO BE TREATED VIA A SIMPLIFIED SURGICAL OPERATION METHOD; AND THEREBY PROMOTION OF RAPIDER AND MORE EFFECTIVE CARTILAGE GENERATION, RESULTING IN IMPROVED CUSTOMER SATISFACTION.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI20080125 MY144022A (en) | 2008-01-22 | 2008-01-22 | Simple method of transplanting injectable chondrocyte for autologous chondrocyte transplantation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI20080125 MY144022A (en) | 2008-01-22 | 2008-01-22 | Simple method of transplanting injectable chondrocyte for autologous chondrocyte transplantation |
Publications (1)
Publication Number | Publication Date |
---|---|
MY144022A true MY144022A (en) | 2011-07-29 |
Family
ID=45024100
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI20080125 MY144022A (en) | 2008-01-22 | 2008-01-22 | Simple method of transplanting injectable chondrocyte for autologous chondrocyte transplantation |
Country Status (1)
Country | Link |
---|---|
MY (1) | MY144022A (en) |
-
2008
- 2008-01-22 MY MYPI20080125 patent/MY144022A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10898497B2 (en) | Compositions and methods for cartilage repair | |
Parisi-Amon et al. | Protein-engineered injectable hydrogel to improve retention of transplanted adipose-derived stem cells | |
Colnot | Cell sources for bone tissue engineering: insights from basic science | |
HRP20110321T1 (en) | Simple method of transplanting injectable chondrocyte for autologous chondrocyte transplantation | |
BR112013000515B1 (en) | METHOD FOR PRODUCING A RECOMBINANT VON WILLEBRAND FACTOR COMPOSITION (RVWF) | |
CN102630157B (en) | Injectable compositions for intra-articular use combining a viscosupplementation agent and a fibroblast growth medium | |
Miller et al. | Growth factor delivery through self-assembling peptide scaffolds | |
Gugjoo et al. | Animal mesenchymal stem cell research in cartilage regenerative medicine–a review | |
WO2009085969A2 (en) | Compositions and methods to promote implantation and engrafment of stem cells | |
Barrachina et al. | Practical considerations for clinical use of mesenchymal stem cells: From the laboratory to the horse | |
CA2551525C (en) | Pharmaceutical composition for thrombin peptide derivatives | |
KR100803576B1 (en) | A composition for transplant comprising adipose stem cells and adipocytes | |
CN104962517A (en) | Preparation, induced differentiation and application of self-assembled mesenchymal stem cell aggregate | |
Bakshi et al. | A chemotactic functional scaffold with VEGF-releasing peptide amphiphiles facilitates bone regeneration by BMP-2 in a large-scale rodent cranial defect model | |
Citterio et al. | Stem cells and periodontal regeneration: present and future | |
Lyu et al. | Parathyroid hormone 1 receptor signaling in dental mesenchymal stem cells: basic and clinical implications | |
HRP20110391T1 (en) | Osteoblast composition of semi-solidified mixed fibrin for bone fracture agglutination and its manufacturing method | |
MY144022A (en) | Simple method of transplanting injectable chondrocyte for autologous chondrocyte transplantation | |
Vallim et al. | Atrophic nonunion stromal cells form bone and recreate the bone marrow environment in vivo | |
KR100956267B1 (en) | A semi-floating composition for transplant comprising elastin as a stabilizing agent | |
CN110755451A (en) | Mesenchymal stem cell composition for treating osteoarthritis and application thereof | |
Yamazaki et al. | Integrated Bone Formation Through In Vivo Endochondral Ossification Using Mesenchymal Stem Cells | |
Yamazaki et al. | Author Spotlight: Enhancing Bone Regeneration with Vascularized Artificial Cartilage Integration | |
CN107320714A (en) | Uncarboxylated BGP promotes the new opplication of insulin secretion | |
US20210137990A1 (en) | Methods for exp anding adipose-derived stem cells |